Evidence map›Paper›PMID 40097447›Full record

ArticleScientific reports2025

Estimating the causal impact of non-pharmaceutical interventions on COVID-19 spread in seven EU countries via machine learning.

Jannis Guski, Jonas Botz, Holger Fröhlich

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jannis GuskiDepartment of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), Sankt Augustin, 53757, Germany. jannis.guski@scai.fraunhofer.de.
Jonas BotzDepartment of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), Sankt Augustin, 53757, Germany.
Holger FröhlichDepartment of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), Sankt Augustin, 53757, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the COVID-19 pandemic, Non-Pharmaceutical Interventions (NPIs) were imposed all over Europe with the intent to reduce infection spread. However, reports on the effectiveness of those measures across different European countries are inconclusive up to now. Moreover, attempts to predict the effect of NPIs in a prospective and dynamical manner with the aim to support decision makers in future global health emergencies are largely lacking. Here, we explore causal machine learning to isolate causal effects of NPIs in observational public health data from seven EU countries, taking into account specific challenges like their sequential nature, effect heterogeneity, time-dependent confounding and lack of robustness due to violated assumptions. In a pseudo-prospective scenario planning analysis, we investigate which recommendations our model would have made during the second wave of the pandemic in Germany, demonstrating its capacity to generalize to the near future and identifying effective NPIs. In retrospect, our approach indicates that a wide range of response measures curbed COVID-19 across countries, especially in the early phases of the pandemic. Interestingly, this includes controversial interventions like strict school and border closures, but also recommendation-based policies in Sweden. Finally, we discuss important data- and modeling-related considerations that may optimize causal effect estimation in future pandemics.

Indexed as

COVID-19Machine LearningEuropeEuropean UnionHumansPandemicsSARS-CoV-2Causal machine learningPolicy recommendationTime-dependent confounding

Identifiers

PMID40097447
PMCPMC11914055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.